Results 231 to 240 of about 213,607 (256)

Recommendation for use of a long-acting monoclonal antibody to prevent respiratory syncytial virus infection in infants and young children. [PDF]

Clin Exp Pediatr
Choi SH, Kim DH, Ahn JG, Yun KW, Eun BW, Lee J, Lee J, Lee TJ, Lee H, Jo DS, Cho EY, Cho HK, Choe YJ, Choi UY, Kim YK, Committee on Infectious Diseases of the Korean Pediatric Society.   +15 more
europepmc   +1 more source

Macronutrients, Micronutrients, and Malnutrition: Effects of Nutrition on Immune Function in Infants and Young Children. [PDF]

Nutrients
van Neerven RJJ.
europepmc   +1 more source

Family caregiver observations of pain behaviors in infants and young children less than 3 years of age. [PDF]

J Pain
Gustafson KE, Zimmerman KO, Hernandez A, Plyler KE, Zigler CK, Maddux AB, Al-Uzri A, Hornik CD, Meyer M, Stevens B, Kopecky EA, Walco GA, Rockhold FW, Reeve BB.   +13 more
europepmc   +1 more source

Respiratory syncytial virus (RSV) notifications and trends in the transmission cycles from infants and young children to older adults in Ireland: an analysis of incidence shifts over a decade. [PDF]

BMJ Open
Philip RK, Mangroo K, Gendy N, Purtill H, Kelly E, Domegan L, O'Leary M.   +6 more
europepmc   +1 more source

Subcortical neural response to click and speech stimuli in infants and young children with congenital cytomegalovirus: a preliminary study. [PDF]

Codas
Silva KSS, Ferreira JVM, Câmara LLP, Bezerra MTAL, Balen SA.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Sexual health among adolescent and young adult cancer survivors: A scoping review from the Children's Oncology Group Adolescent and Young Adult Oncology Discipline Committee

Ca-A Cancer Journal for Clinicians, 2021
David R Freyer, Natasha N Frederick, Kristin Bingen   +2 more
exaly  

Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children

Genetics in Medicine, 2022
Daniella Magen, Bruno Ranchin, John C Lieske   +2 more
exaly